Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content